textabstractAbstract. Background: Low disease prevalence and lack of uniform reference standards in primary care induce methodological challenges for investigating the diagnostic accuracy of a test. We present a study design that copes with these methodological challenges and discuss the methodological implications of our choices, using a quality assessment tool for diagnostic accuracy studies (QUADAS-2). Design. The study investigates the diagnostic value of fecal calprotectin for detecting inflammatory bowel disease in children presenting with chronic gastrointestinal symptoms in primary care. It is a prospective cohort study including two cohorts of children: one cohort will be recruited in primary care and the other in secondary/tertiar...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Background: Faecal calprotectin (FC) testing has received national approval for the detection of inf...
Introduction: Decisions about test availability for patient care are often based on limited evidence...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Abstract. Background: Low disease prevalence and lack of uniform reference standards in primary care...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Background: Faecal calprotectin (FC) testing has received national approval for the detection of inf...
Introduction: Decisions about test availability for patient care are often based on limited evidence...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Abstract. Background: Low disease prevalence and lack of uniform reference standards in primary care...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
Background: Low disease prevalence and lack of uniform reference standards in primary care induce me...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Background: Faecal calprotectin (FC) testing has received national approval for the detection of inf...
Introduction: Decisions about test availability for patient care are often based on limited evidence...